Donor Th2 cell therapy

donor T helper 2 cells · National Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Donor Th2 cell therapy, covering 2018-07-05 to 2018-07-05. Get the full timeline:

Most recent: Clinical Trial Update: Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [Phase 1]